Emerald Clinical Trials Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
500
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
- Investments
-
1
Emerald Clinical Trials General Information
Description
Provider of clinical trial services intended for biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials. The company offers clinical research services, medical writing, health economics, statistics services, endpoint adjudication, and medical monitoring, providing clients with access to the clinical trial markets in the world.
Contact Information
Website
www.emeraldclinical.comCorporate Office
- Level 19, 323 Castlereagh Street
- Suite 19.01, Newtown
- Sydney, New South Wales 2000
- Australia
Corporate Office
- Level 19, 323 Castlereagh Street
- Suite 19.01, Newtown
- Sydney, New South Wales 2000
- Australia
Emerald Clinical Trials Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Emerald Clinical Trials Comparisons
Industry
Financing
Details
Emerald Clinical Trials Competitors (2)
One of Emerald Clinical Trials’s 2 competitors is Mobius Medical, a Corporation company based in North Sydney, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mobius Medical | Corporation | North Sydney, Australia | ||||
| Southern Star Research | Private Equity-Backed | Gordon, Australia |
Emerald Clinical Trials Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Emerald Clinical Trials Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Emerald Clinical Trials Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Emerald Clinical Trials Acquisitions (1)
Emerald Clinical Trials’s most recent deal was a Merger/Acquisition with Vector Oncology (CRO Division). The deal was made on 02-May-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vector Oncology (CRO Division) | 02-May-2017 | Merger/Acquisition | Other Healthcare Services |
Emerald Clinical Trials FAQs
-
When was Emerald Clinical Trials founded?
Emerald Clinical Trials was founded in 2008.
-
Where is Emerald Clinical Trials headquartered?
Emerald Clinical Trials is headquartered in Sydney, Australia.
-
What is the size of Emerald Clinical Trials?
Emerald Clinical Trials has 500 total employees.
-
What industry is Emerald Clinical Trials in?
Emerald Clinical Trials’s primary industry is Other Healthcare Services.
-
Is Emerald Clinical Trials a private or public company?
Emerald Clinical Trials is a Private company.
-
What is the current valuation of Emerald Clinical Trials?
The current valuation of Emerald Clinical Trials is .
-
What is Emerald Clinical Trials’s current revenue?
The current revenue for Emerald Clinical Trials is .
-
How much funding has Emerald Clinical Trials raised over time?
Emerald Clinical Trials has raised $12.9M.
-
Who are Emerald Clinical Trials’s investors?
Hillhouse Investment Group has invested in Emerald Clinical Trials.
-
Who are Emerald Clinical Trials’s competitors?
Mobius Medical and Southern Star Research are competitors of Emerald Clinical Trials.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
